Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–5 of 5 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791
- Conditions
- Cancer of Rectum, Cancer of the Rectum, Colorectal Neoplasms, +15 more
- Locations
-
- Wuhan Union Hospital Wuhan, Hubei, China
- Hubei Cancer Hospital Wuhan, Hubei, China
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- GSK Investigational Site Busan, South Korea
- GSK Investigational Site Chungcheongnam-do, South Korea
- GSK Investigational Site Daegu, South Korea
- GSK Investigational Site Gongju-si, Chungcheongnam-do, South Korea
Completed
Immunoscore in Rectal Cancer
NCT02017509
- Conditions
- Cancer of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +13 more
- Locations
-
- Providence Health & Services Portland, Oregon, United States
- Oregon Health & Science University Portland, Oregon, United States
Active, Not Recruiting
A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer
NCT05723562
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Albuquerque, New Mexico, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
NCT06640049
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- GSK Investigational Site Chengdu, China
- GSK Investigational Site Chongqing, China
- GSK Investigational Site Guangzhou, China
- GSK Investigational Site Guangzhou, China